Literature DB >> 2419418

Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.

B Mukherji, S A Wilhelm, A Guha, M T Ergin.   

Abstract

The potential existence of down-regulation of cytotoxic immune response against an autologous human melanoma line was investigated as a possible explanation for cytotoxic unresponsiveness against the autologous melanoma cells. The melanoma cell line, PJ-M, was established and lymph node resident lymphocytes (LNL) were isolated from a lymph node which was partially infiltrated with the melanoma cells. Autologous peripheral blood lymphocytes (PBL) were sensitized in in vitro co-culture (IVC) against radiated PJ-M cells in the presence or absence of PJ-M-sensitized LNL and enriched suppressor (OKT8+) or inducer (OKT4+) LNL populations, and were assayed for cytotoxicity in a 4-hr 51Cr-release microcytotoxicity assay. Significant cytotoxic response against PJ-M could be generated in the PBL, but not in the LNL. The addition of sensitized, unfractionated LNL, OKT8+, or OKT4+ LNL populations abrogated cytotoxic response in the PBL against PJ-M. The suppression of cytotoxic response was induced selectively against the PJ-M targets, because IVC of PBL in the presence of the sensitized LNL did not affect the generation of polyclonal cytotoxic alloreactivities, nor did they abrogate the generation of cytotoxic response against allogeneic targets in IVC against the corresponding allogeneic targets. These results suggest the possibility that cytotoxic immune response against the autologous melanoma cells might have been suppressed by the individual's own immunoregulatory circuit.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2419418

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Selection of cytotoxic T lymphocytes against autologous human melanoma from lymph nodes with metastatic melanoma using repeated in vitro sensitization.

Authors:  S P Leong; M E Granberry; Y M Zhou; T F Wang; T M Grogan
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

2.  Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications.

Authors:  K F Yoong; D H Adams
Journal:  Clin Mol Pathol       Date:  1996-10

3.  Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells.

Authors:  M Radrizzani; C Gambacorti-Passerini; G Parmiani; G Fossati
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes.

Authors:  D Taramelli; A Mazzocchi; C Clemente; G Fossati; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Active immunotherapy with viral lysates of micrometastases following surgical removal of high risk melanoma.

Authors:  P Hersey
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

6.  NKG2D ligand expression in pediatric brain tumors.

Authors:  Kristen Haberthur; Kathryn Brennan; Virginia Hoglund; Stephanie Balcaitis; Harrison Chinn; Amira Davis; Shannon Kreuser; Conrad Winter; Sarah E S Leary; Gail H Deutsch; Richard G Ellenbogen; Courtney A Crane
Journal:  Cancer Biol Ther       Date:  2016-11-11       Impact factor: 4.742

7.  Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A.

Authors:  Y Hayashi; D S Hoon; M S Park; P I Terasaki; D L Morton
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

8.  Phenotypic analysis of nylon-wool-adherent suppressor cells that inhibit the effector process of tumour cell lysis by lymphokine-activated killer cells in patients with advanced gastric carcinoma.

Authors:  S Koyama; K Fukao
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

9.  Generation of cytotoxic effector cells against human melanoma.

Authors:  S P Leong; Y M Zhou; M E Granberry; T F Wang; T M Grogan; C Spier; R White; A Mehta; A Y Lin
Journal:  Cancer Immunol Immunother       Date:  1995-06       Impact factor: 6.968

10.  Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients.

Authors:  M Eura; T Maehara; T Ikawa; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.